Literature DB >> 19492146

VKORC1 deficiency in mice causes early postnatal lethality due to severe bleeding.

Gabriele Spohn1, Andre Kleinridders, F Thomas Wunderlich, Matthias Watzka, Frank Zaucke, Katrin Blumbach, Christof Geisen, Erhard Seifried, Clemens Müller, Mats Paulsson, Jens C Brüning, Johannes Oldenburg.   

Abstract

Vitamin K hydroquinone is oxidised to the epoxide form (K>O) during vitamin K-dependent posttranslational gamma-glutamyl carboxylation resulting in biological active so called vitamin K-dependent proteins. In turn, K>O is reduced by the enzyme VKORC1 (vitamin K epoxide reductase complex component 1) to complete the vitamin K cycle. To investigate the biological role of VKORC1 in vivo, we generated VKORC1 knockout mice. Homozygous VKORC1-deficient mice developed normally until birth. Within 2-20 days after birth, the knockout mice died due to extensive, predominantly intracerebral haemorrhage. Bleeding resulted from a severe deficiency of gamma-carboxylated clotting factors. This lethal phenotype could be rescued by oral administration of vitamin K. Additionally, morphometric analysis of the limbs in VKORC1-deficient animals revealed reduced length of bone calcification relative to wild-type control mice. The observed phenotype of VKORC1 knockout mice excludes the existence of other enzymes with VKOR activity that can substitute to supply vitamin K hydroquinone required for maturation of blood clotting factors. Thus, our study underscores the essential role of VKORC1 in vitamin K-dependent gamma-glutamyl carboxylation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19492146

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  29 in total

1.  Mycobacterium tuberculosis vitamin K epoxide reductase homologue supports vitamin K-dependent carboxylation in mammalian cells.

Authors:  Jian-Ke Tie; Da-Yun Jin; Darrel W Stafford
Journal:  Antioxid Redox Signal       Date:  2011-11-22       Impact factor: 8.401

2.  Novel insight into the mechanism of the vitamin K oxidoreductase (VKOR): electron relay through Cys43 and Cys51 reduces VKOR to allow vitamin K reduction and facilitation of vitamin K-dependent protein carboxylation.

Authors:  Mark A Rishavy; Aisulu Usubalieva; Kevin W Hallgren; Kathleen L Berkner
Journal:  J Biol Chem       Date:  2010-10-26       Impact factor: 5.157

3.  Functional Study of the Vitamin K Cycle Enzymes in Live Cells.

Authors:  J-K Tie; D W Stafford
Journal:  Methods Enzymol       Date:  2016-11-22       Impact factor: 1.600

4.  Warfarin alters vitamin K metabolism: a surprising mechanism of VKORC1 uncoupling necessitates an additional reductase.

Authors:  Mark A Rishavy; Kevin W Hallgren; Lee Wilson; Savita Singh; Kurt W Runge; Kathleen L Berkner
Journal:  Blood       Date:  2018-03-28       Impact factor: 22.113

5.  Human vitamin K 2,3-epoxide reductase complex subunit 1-like 1 (VKORC1L1) mediates vitamin K-dependent intracellular antioxidant function.

Authors:  Philipp Westhofen; Matthias Watzka; Milka Marinova; Moritz Hass; Gregor Kirfel; Jens Müller; Carville G Bevans; Clemens R Müller; Johannes Oldenburg
Journal:  J Biol Chem       Date:  2011-03-02       Impact factor: 5.157

6.  VKOR paralog VKORC1L1 supports vitamin K-dependent protein carboxylation in vivo.

Authors:  Julie Lacombe; Mark A Rishavy; Kathleen L Berkner; Mathieu Ferron
Journal:  JCI Insight       Date:  2018-01-11

Review 7.  Recent trends in the metabolism and cell biology of vitamin K with special reference to vitamin K cycling and MK-4 biosynthesis.

Authors:  Martin J Shearer; Paul Newman
Journal:  J Lipid Res       Date:  2014-01-31       Impact factor: 5.922

Review 8.  Vitamin K and hepatocellular carcinoma: The basic and clinic.

Authors:  Xia Jinghe; Toshihiko Mizuta; Iwata Ozaki
Journal:  World J Clin Cases       Date:  2015-09-16       Impact factor: 1.337

9.  Warfarin and vitamin K compete for binding to Phe55 in human VKOR.

Authors:  Katrin J Czogalla; Arijit Biswas; Klara Höning; Veit Hornung; Kerstin Liphardt; Matthias Watzka; Johannes Oldenburg
Journal:  Nat Struct Mol Biol       Date:  2016-12-12       Impact factor: 15.369

10.  Evaluation of warfarin resistance using transcription activator-like effector nucleases-mediated vitamin K epoxide reductase knockout HEK293 cells.

Authors:  J-K Tie; D-Y Jin; K Tie; D W Stafford
Journal:  J Thromb Haemost       Date:  2013-08       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.